How did PTIX's R&D expenses trend in Q4 2024?
5/9/2025 03:41am
Protagenic (PTIX) saw a significant increase in R&D expenses in Q4 2024, with the figure reaching $903,362. This represents a notable rise from the previous quarter, indicating a strong commitment to research and development during the period.
|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|PTIX|PTIX.O|Protagenic|2024 Q1|1460746|319.71720909918946|186|
|PTIX|PTIX.O|Protagenic|2024 Q2|1214049|45.15536616773018|186|
|PTIX|PTIX.O|Protagenic|2024 Q3|364184|-67.60015302082685|186|
|PTIX|PTIX.O|Protagenic|2024 Q4|903362|-10.684409255438108|186|